Cancer evolution: Darwin and beyond
Clinical and laboratory studies over recent decades have established branched evolution as
a feature of cancer. However, while grounded in somatic selection, several lines of evidence …
a feature of cancer. However, while grounded in somatic selection, several lines of evidence …
[PDF][PDF] Clonal heterogeneity and tumor evolution: past, present, and the future
N McGranahan, C Swanton - Cell, 2017 - cell.com
Intratumor heterogeneity, which fosters tumor evolution, is a key challenge in cancer
medicine. Here, we review data and technologies that have revealed intra-tumor …
medicine. Here, we review data and technologies that have revealed intra-tumor …
[HTML][HTML] Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
Abiraterone treats metastatic castrate-resistant prostate cancer by inhibiting CYP17A, an
enzyme for testosterone auto-production. With standard dosing, evolution of resistance with …
enzyme for testosterone auto-production. With standard dosing, evolution of resistance with …
Enabling technologies for personalized and precision medicine
Individualizing patient treatment is a core objective of the medical field. Reaching this
objective has been elusive owing to the complex set of factors contributing to both disease …
objective has been elusive owing to the complex set of factors contributing to both disease …
Integrating evolutionary dynamics into cancer therapy
RA Gatenby, JS Brown - Nature reviews Clinical oncology, 2020 - nature.com
Many effective drugs for metastatic and/or advanced-stage cancers have been developed
over the past decade, although the evolution of resistance remains the major barrier to …
over the past decade, although the evolution of resistance remains the major barrier to …
From tumour heterogeneity to advances in precision treatment of colorectal cancer
CJA Punt, M Koopman, L Vermeulen - Nature reviews Clinical oncology, 2017 - nature.com
In recent years, the high heterogeneity of colorectal cancer (CRC) has become evident.
Hence, biomarkers need to be developed that enable the stratification of patients with CRC …
Hence, biomarkers need to be developed that enable the stratification of patients with CRC …
Chemotherapy resistance in advanced ovarian cancer patients
R Pokhriyal, R Hariprasad, L Kumar… - Biomarkers in …, 2019 - journals.sagepub.com
Ovarian cancer is the seventh most common gynaecologic malignancy seen in women.
Majority of the patients with ovarian cancer are diagnosed at the advanced stage making …
Majority of the patients with ovarian cancer are diagnosed at the advanced stage making …
The mathematics of cancer: integrating quantitative models
Mathematical modelling approaches have become increasingly abundant in cancer
research. The complexity of cancer is well suited to quantitative approaches as it provides …
research. The complexity of cancer is well suited to quantitative approaches as it provides …
[HTML][HTML] Biological and therapeutic impact of intratumor heterogeneity in cancer evolution
N McGranahan, C Swanton - Cancer cell, 2015 - cell.com
Precision medicine requires an understanding of cancer genes and mutational processes,
as well as an appreciation of the extent to which these are found heterogeneously in cancer …
as well as an appreciation of the extent to which these are found heterogeneously in cancer …
Tumor microenvironment and differential responses to therapy
E Hirata, E Sahai - Cold Spring Harbor …, 2017 - perspectivesinmedicine.cshlp.org
Cancer evolution plays a key role in both the development of tumors and their response to
therapy. Like all evolutionary processes, tumor evolution is shaped by the environment. In …
therapy. Like all evolutionary processes, tumor evolution is shaped by the environment. In …